AD
Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care.
Arthritis Rheum 62(3):293-5 (2010) PMID 20391473
DOI: 10.1002/acr.20088
Version: za2963e q8za2 q8zb7 q8zc4 q8zd1 q8zed q8zf7 q8zgd
AD